Literature DB >> 32303698

A map of SARS-CoV-2 and host cell interactions.

Louise Malle1.   

Abstract

Entities:  

Year:  2020        PMID: 32303698      PMCID: PMC7186929          DOI: 10.1038/s41577-020-0318-1

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   108.555


× No keyword cloud information.
Currently, little is known about the molecular interactions between SARS-CoV-2 and its host. In this preprint, Gordon et al. cloned, tagged and expressed 26 of 29 SARS-CoV-2 proteins individually in HEK293T cells and used mass spectrometry to measure protein–protein interactions. They identified 332 interactions between viral and host proteins, and several viral proteins (including N, nsp9, nsp13, nsp15, ORF3a and ORF6) were found to directly target cellular proteins involved in innate immune signalling. Furthermore, they noted 69 existing drugs known to target host proteins or associated pathways that interact with SARS-CoV-2. Overall, this ‘SARS-CoV-2 interaction map’ paves the way to better understand how the virus hijacks its host during infection and provides promising therapeutic candidates.
  1 in total

1.  A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing.

Authors:  David E Gordon; Gwendolyn M Jang; Mehdi Bouhaddou; Jiewei Xu; Kirsten Obernier; Matthew J O'Meara; Jeffrey Z Guo; Danielle L Swaney; Tia A Tummino; Ruth Hüttenhain; Robyn M Kaake; Alicia L Richards; Beril Tutuncuoglu; Helene Foussard; Jyoti Batra; Kelsey Haas; Maya Modak; Minkyu Kim; Paige Haas; Benjamin J Polacco; Hannes Braberg; Jacqueline M Fabius; Manon Eckhardt; Margaret Soucheray; Melanie J Bennett; Merve Cakir; Michael J McGregor; Qiongyu Li; Zun Zar Chi Naing; Yuan Zhou; Shiming Peng; Ilsa T Kirby; James E Melnyk; John S Chorba; Kevin Lou; Shizhong A Dai; Wenqi Shen; Ying Shi; Ziyang Zhang; Inigo Barrio-Hernandez; Danish Memon; Claudia Hernandez-Armenta; Christopher J P Mathy; Tina Perica; Kala B Pilla; Sai J Ganesan; Daniel J Saltzberg; Rakesh Ramachandran; Xi Liu; Sara B Rosenthal; Lorenzo Calviello; Srivats Venkataramanan; Yizhu Lin; Stephanie A Wankowicz; Markus Bohn; Raphael Trenker; Janet M Young; Devin Cavero; Joe Hiatt; Theo Roth; Ujjwal Rathore; Advait Subramanian; Julia Noack; Mathieu Hubert; Ferdinand Roesch; Thomas Vallet; Björn Meyer; Kris M White; Lisa Miorin; David Agard; Michael Emerman; Davide Ruggero; Adolfo García-Sastre; Natalia Jura; Mark von Zastrow; Jack Taunton; Olivier Schwartz; Marco Vignuzzi; Christophe d'Enfert; Shaeri Mukherjee; Matt Jacobson; Harmit S Malik; Danica G Fujimori; Trey Ideker; Charles S Craik; Stephen Floor; James S Fraser; John Gross; Andrej Sali; Tanja Kortemme; Pedro Beltrao; Kevan Shokat; Brian K Shoichet; Nevan J Krogan
Journal:  bioRxiv       Date:  2020-03-22
  1 in total
  6 in total

1.  SARS-CoV-2 (COVID-19) structural and evolutionary dynamicome: Insights into functional evolution and human genomics.

Authors:  Ruchir Gupta; Jacob Charron; Cynthia L Stenger; Jared Painter; Hunter Steward; Taylor W Cook; William Faber; Austin Frisch; Eric Lind; Jacob Bauss; Xiaopeng Li; Olivia Sirpilla; Xavier Soehnlen; Adam Underwood; David Hinds; Michele Morris; Neil Lamb; Joseph A Carcillo; Caleb Bupp; Bruce D Uhal; Surender Rajasekaran; Jeremy W Prokop
Journal:  J Biol Chem       Date:  2020-06-25       Impact factor: 5.157

2.  The study of antiviral drugs targeting SARS-CoV-2 nucleocapsid and spike proteins through large-scale compound repurposing.

Authors:  Xuqiao Hu; Zhenru Zhou; Fei Li; Yang Xiao; Zhaoyang Wang; Jinfeng Xu; Fajin Dong; Hairong Zheng; Rongmin Yu
Journal:  Heliyon       Date:  2021-03-01

3.  Evaluation of mid- and long-term impact of COVID-19 on male fertility through evaluating semen parameters.

Authors:  Bintao Hu; Kang Liu; Yajun Ruan; Xian Wei; Yue Wu; Huan Feng; Zhiyao Deng; Jihong Liu; Tao Wang
Journal:  Transl Androl Urol       Date:  2022-02

Review 4.  COVID-19: Where is the treatment?

Authors:  Bonala Sabeerabi; Sarojamma Vemula; Ramakrishna Vadde; Ganji Purnachandra Nagaraju
Journal:  World J Clin Oncol       Date:  2021-05-24

5.  Challenges in Repurposing Drugs in COVID-19 Pandemic. Debating on Potential New Refinements.

Authors:  Giorgio Frega; Andrea Palloni; Giuseppe Di Pasquale; Gioconda Saccoccio; Alessandro Rizzo; Elisabetta Poluzzi; Primiano Iannone; Giovanni Brandi
Journal:  Front Pharmacol       Date:  2020-10-28       Impact factor: 5.810

6.  Role of SARS-CoV-2 in Altering the RNA-Binding Protein and miRNA-Directed Post-Transcriptional Regulatory Networks in Humans.

Authors:  Rajneesh Srivastava; Swapna Vidhur Daulatabad; Mansi Srivastava; Sarath Chandra Janga
Journal:  Int J Mol Sci       Date:  2020-09-25       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.